These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 3570418

  • 1. Cytological mass screening in Ostfold County, Norway.
    Magnus K, Langmark F.
    IARC Sci Publ; 1986; (76):87-90. PubMed ID: 3570418
    [No Abstract] [Full Text] [Related]

  • 2. Cervical cancer screening in north-east Scotland.
    Macgregor JE, Moss S, Parkin DM, Day NE.
    IARC Sci Publ; 1986; (76):25-36. PubMed ID: 3570409
    [No Abstract] [Full Text] [Related]

  • 3. Results from a cervical cancer screening programme in Manitoba, Canada.
    Choi NW, Nelson NA.
    IARC Sci Publ; 1986; (76):61-7. PubMed ID: 3570416
    [No Abstract] [Full Text] [Related]

  • 4. [HPV test for quality control of gynecologic cytological tests].
    Wilander E, Wikström I.
    Lakartidningen; 1986; 105(48-49):3560, 3564. PubMed ID: 19133586
    [No Abstract] [Full Text] [Related]

  • 5. Screening for squamous cervical cancer--the duration of low risk following negative results in cervical cytology test: introduction. IARC Working Group on Cervical Cancer Screening.
    IARC Sci Publ; 1986; (76):15-24. PubMed ID: 3570401
    [No Abstract] [Full Text] [Related]

  • 6. Cytological screening history of patients with early invasive cervical cancer.
    Turner MJ, Keane DP, Flannelly GM, Lenehan PM, Murphy JF, Foley ME.
    Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
    [Abstract] [Full Text] [Related]

  • 7. False negative rate in mass screening for cervical cancer.
    Sato S, Mikino H, Matsunaga G, Yajima A.
    Acta Cytol; 1998 Jun; 42(3):836-7. PubMed ID: 9622728
    [No Abstract] [Full Text] [Related]

  • 8. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A, Phillips N, Kan L, Matisic J, Benedet L, Towers L.
    J Med Screen; 2005 Jun; 12(1):7-11. PubMed ID: 15814014
    [Abstract] [Full Text] [Related]

  • 9. NIH Consensus Development Panel summary, Cervical cancer screening: the Pap smear.
    South Med J; 1981 Jan; 74(1):87-8. PubMed ID: 7455757
    [No Abstract] [Full Text] [Related]

  • 10. Cervical carcinoma in Nigeria--a need for early detection.
    Edozien LC, Adewole IF.
    Afr J Med Med Sci; 1993 Dec; 22(4):87-92. PubMed ID: 7839937
    [No Abstract] [Full Text] [Related]

  • 11. [Mass screening for cervical cancer. A one-year registration of cervical cytological tests].
    Bjørge T, Gunbjørud AB, Langmark F, Skare GB, Thoresen SO.
    Tidsskr Nor Laegeforen; 1994 Jan 30; 114(3):341-5. PubMed ID: 8191435
    [Abstract] [Full Text] [Related]

  • 12. [Incidence and mortality of uterine cervix cancer in Norway. When do we get organized nation-wide cytologic screening in Norway?].
    Magnus K, Langmark F.
    Tidsskr Nor Laegeforen; 1990 May 10; 110(12):1557-9. PubMed ID: 2187277
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the effect of Papanicolaou screening in Sweden: record linkage between a central screening registry and the National Cancer Registry.
    Pettersson F, Näslund I, Malker B.
    IARC Sci Publ; 1986 May 10; (76):91-105. PubMed ID: 3570419
    [Abstract] [Full Text] [Related]

  • 14. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 15. Cervical mass screening in Norway--510,000 smears a year.
    Bjørge T, Gunbjørud AB, Langmark F, Skare GB, Thoresen SO.
    Cancer Detect Prev; 1994 May 07; 18(6):463-70. PubMed ID: 7867019
    [Abstract] [Full Text] [Related]

  • 16. [Vaginal cytological examination in the County of Arhus. Extent of screening in a county without a systematic screening program].
    Olesen F.
    Ugeskr Laeger; 1984 Jul 30; 146(31):2325-9. PubMed ID: 6515834
    [No Abstract] [Full Text] [Related]

  • 17. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A, Seidal T, Grannas M, Hagmar B.
    Acta Obstet Gynecol Scand; 2000 Mar 30; 79(3):221-6. PubMed ID: 10716304
    [Abstract] [Full Text] [Related]

  • 18. Cytological screening for precancerous lesions of the cervix.
    Sng I.
    Singapore Med J; 1987 Oct 30; 28(5):415-21. PubMed ID: 3433107
    [No Abstract] [Full Text] [Related]

  • 19. [Cytological mass screenings for the cancer of the cervix uteri. Resources, organization and costs].
    Kolstad P.
    Tidsskr Nor Laegeforen; 1988 Sep 10; 108(25):2057-60. PubMed ID: 3201418
    [No Abstract] [Full Text] [Related]

  • 20. [Carcinoma in situ of the portio vaginalis uteri (increased atypical squamous epithelium, H3) as a special stage in the canceration process. (Prevention of cervix carcinomas)].
    Buchmann E, Kaiser P, Moltz L.
    Zentralbl Gynakol; 1972 Jan 22; 94(3):87-93. PubMed ID: 5017234
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.